» Articles » PMID: 30167387

Using Laboratory Data to Categorise CD4 Laboratory Turn-around-time Performance Across a National Programme

Overview
Journal Afr J Lab Med
Date 2018 Sep 1
PMID 30167387
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objective: The National Health Laboratory Service provides CD4 testing through an integrated tiered service delivery model with a target laboratory turn-around time (TAT) of 48 h. Mean TAT provides insight into national CD4 laboratory performance. However, it is not sensitive enough to identify inefficiencies of outlying laboratories or predict the percentage of samples meeting the TAT target. The aim of this study was to describe the use of the median, 75th percentile and percentage within target of laboratory TAT data to categorise laboratory performance.

Methods: Retrospective CD4 laboratory data for 2015-2016 fiscal year were extracted from the corporate data warehouse. The laboratory TAT distribution and percentage of samples within the 48 h target were assessed. A scatter plot was used to categorise laboratory performance into four quadrants using both the percentage within target and 75th percentile TAT. The laboratory performance was labelled good, satisfactory or poor.

Results: TAT data reported a positive skew with a mode of 13 h and a median of 17 h and 75th percentile of 25 h. Overall, 93.2% of CD4 samples had a laboratory TAT of less than 48 h. 48 out of 52 laboratories reported good TAT performance, i.e. percentage within target > 85% and 75th percentile ≤ 48 h, with two categorised as satisfactory (one parameter met), and two as poor performing laboratories (failed both parameters).

Conclusion: This study demonstrated the feasibility of utilising laboratory data to categorise laboratory performance. Using the quadrant approach for TAT data, laboratories that need interventions can be highlighted for root cause analysis assessment.

Citing Articles

Newly implemented community CD4 service in Tshwaragano, Northern Cape province, South Africa, positively impacts result turn-around time.

Coetzee L, Cassim N, Glencross D Afr J Lab Med. 2022; 11(1):1376.

PMID: 35811752 PMC: 9257740. DOI: 10.4102/ajlm.v11i1.1376.


Retrospective Assessment of a National Reflex Cryptococcal Antigen Screening Program in South Africa Through Interlaboratory Comparison of Lateral Flow Assay Results.

Blasich N, Coetzee L, Sriruttan C, DeSanto D, Greene G, Glencross D Lab Med. 2022; 53(6):614-618.

PMID: 35660925 PMC: 9631796. DOI: 10.1093/labmed/lmac037.


Categorising specimen referral delays for CD4 testing: How inter-laboratory distances and travel times impact turn-around time across a national laboratory service in South Africa.

Cassim N, Coetzee L, Glencross D Afr J Lab Med. 2021; 9(1):1120.

PMID: 33392053 PMC: 7756670. DOI: 10.4102/ajlm.v9i1.1120.


Weekly laboratory turn-around time identifies poor performance masked by aggregated reporting.

Coetzee L, Cassim N, Glencross D Afr J Lab Med. 2021; 9(1):1102.

PMID: 33392052 PMC: 7756605. DOI: 10.4102/ajlm.v9i1.1102.


Using Systematized Nomenclature of Medicine clinical term codes to assign histological findings for prostate biopsies in the Gauteng province, South Africa: Lessons learnt.

Cassim N, Ahmad A, Wadee R, George J, Glencross D Afr J Lab Med. 2020; 9(1):909.

PMID: 33102166 PMC: 7565135. DOI: 10.4102/ajlm.v9i1.909.


References
1.
Goswami B, Singh B, Chawla R, Gupta V, Mallika V . Turn Around Time (TAT) as a Benchmark of Laboratory Performance. Indian J Clin Biochem. 2011; 25(4):376-9. PMC: 2994570. DOI: 10.1007/s12291-010-0056-4. View

2.
Archetti C, Montanelli A, Finazzi D, Caimi L, Garrafa E . Clinical Laboratory Automation: A Case Study. J Public Health Res. 2017; 6(1):881. PMC: 5477477. DOI: 10.4081/jphr.2017.881. View

3.
Glencross D, Coetzee L, Cassim N . An integrated tiered service delivery model (ITSDM) based on local CD4 testing demands can improve turn-around times and save costs whilst ensuring accessible and scalable CD4 services across a national programme. PLoS One. 2014; 9(12):e114727. PMC: 4260875. DOI: 10.1371/journal.pone.0114727. View

4.
Imoh L, Mutale M, Parker C, Erasmus R, Zemlin A . Laboratory-based clinical audit as a tool for continual improvement: an example from CSF chemistry turnaround time audit in a South-African teaching hospital. Biochem Med (Zagreb). 2016; 26(2):194-201. PMC: 4910269. DOI: 10.11613/BM.2016.021. View

5.
Larson B, Rockers P, Bonawitz R, Sriruttan C, Glencross D, Cassim N . Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa. PLoS One. 2016; 11(7):e0158986. PMC: 4938608. DOI: 10.1371/journal.pone.0158986. View